The single most damaging misconception that women with polycystic ovary syndrome carry into their family-planning years is the belief that the diagnosis means they cannot get pregnant. The clinical reality is the opposite — the vast majority of women with PCOS can and do conceive, often with no more than a lifestyle change and a few cycles of an oral ovulation induction tablet, and the proportion who genuinely need advanced fertility treatment such as in vitro fertilisation is a small minority. The mechanism behind PCOS-related infertility is irregular or absent ovulation rather than an inability to ever release an egg, which means the fertility task is one of supporting ovulation and timing intercourse rather than overcoming a fundamental block.

The first-line intervention for a woman with PCOS who is having difficulty conceiving is a five to ten percent reduction in body weight if the body mass index is above twenty-five, because the metabolic shift associated with this modest weight loss restores spontaneous ovulation in a majority of overweight women with PCOS and is the single most cost-effective fertility treatment available. The second-line intervention is oral ovulation induction with letrozole at two and a half to five milligrams a day for five days from cycle day two or with clomiphene citrate at fifty to one hundred milligrams a day for five days, both of which are widely available across Indian pharmacies at roughly fifty to three hundred rupees for a cycle's supply and both of which produce ovulation in seventy to eighty percent of women with PCOS within three to six cycles of use.

Metformin at five hundred milligrams once or twice a day to one thousand milligrams twice a day is sometimes added at the obstetrician's discretion to improve insulin resistance, lower androgen levels and modestly improve ovulation rates, and is available across India at roughly one hundred to three hundred rupees a month under brand names including Glycomet and Glyciphage. Intrauterine insemination at fifteen to thirty thousand rupees a cycle is offered if oral ovulation induction does not lead to pregnancy after several cycles or if there is a secondary male-factor or tubal contribution, and in vitro fertilisation at one and a half to three and a half lakh rupees a cycle is reserved for the minority who do not conceive with simpler measures or who have other infertility factors layered on top of PCOS.

• Aim for a body mass index between eighteen and a half and twenty-five before you start trying to conceive, with a five to ten percent reduction in weight from your current starting point being a realistic and clinically meaningful target that restores spontaneous ovulation in many overweight women with PCOS and that lowers the risk of every major pregnancy complication that PCOS predisposes to including gestational diabetes, preeclampsia and a large-for-gestational-age baby.
• Ask your obstetrician for a fasting insulin and a fasting glucose to calculate a HOMA-IR insulin resistance index, and consider starting metformin at five hundred to one thousand milligrams a day if the result is significantly raised, because treating insulin resistance before conception improves ovulation rates, lowers first trimester miscarriage risk and gives the metabolic system a head start before the additional load of pregnancy.
• Get a thyroid stimulating hormone test and treat hypothyroidism aggressively with levothyroxine aiming for a TSH of less than two and a half before conception, because thyroid dysfunction often coexists with PCOS and an undertreated thyroid in early pregnancy compounds the miscarriage and developmental risks that PCOS already raises.
• Start a daily folic acid supplement at four hundred to eight hundred micrograms at least three months before you start trying, stepped up to five milligrams a day if you are obese or have significant insulin resistance, because the higher folate requirement covers the slightly raised neural tube defect risk that runs with both obesity and PCOS-related metabolic patterns.
• Check vitamin D status with a serum 25-hydroxy vitamin D test and supplement to a level above thirty nanograms per millilitre, because the vast majority of Indian women with PCOS run vitamin D deficient and adequate vitamin D is associated with better insulin sensitivity and lower pregnancy complication rates.
• Get a fasting lipid profile and address an abnormal cholesterol or triglyceride pattern before conception with diet and exercise first and with statin therapy stopped before conception if it was previously in use, because lipid abnormalities are common in PCOS and contribute to the raised cardiovascular and preeclampsia risks that the pregnancy will sit on top of.

A PCOS pregnancy carries a measurably higher risk of five specific complications compared with a pregnancy in a woman without PCOS, with the absolute risk for each complication sitting at roughly two to three times the general obstetric population rate. The headline complication is gestational diabetes, which the PCOS metabolic profile of insulin resistance and androgen excess predisposes to and which affects a significantly higher proportion of PCOS pregnancies than general pregnancies. The second is preeclampsia and the broader umbrella of pregnancy-induced hypertension, which is linked both to the underlying insulin resistance and to the higher background body mass index that many PCOS women carry. The third is preterm birth, which can be spontaneous or can be a deliberate early delivery for one of the other complications. The fourth is first trimester miscarriage, with the loss rate in untreated PCOS pregnancies sitting between thirty and fifty percent compared with ten to fifteen percent in the general obstetric population, and the rate falling significantly when insulin resistance and thyroid status are addressed before conception. The fifth is a large-for-gestational-age baby or macrosomia, which is driven by raised maternal blood sugar feeding the fetus and which in turn raises the cesarean section rate.

Two further consequences sit alongside these five. Gestational hypertension that does not progress to full preeclampsia is more common in PCOS pregnancy and adds to the antenatal monitoring load. And the overall cesarean section rate is higher across PCOS pregnancies, partly because of the higher rate of larger babies, partly because of induction of labour for one of the other complications, and partly because of the higher background obesity rate which itself raises operative delivery rates.

The point of laying out these risks plainly is not to frighten a woman with PCOS away from pregnancy or to suggest that a PCOS pregnancy is dangerous. The absolute risks are still small in most cases and the modern antenatal package of early gestational diabetes screening, careful blood pressure monitoring, sensible weight gain targets, low-dose aspirin where appropriate and continued metformin where indicated has substantially closed the outcome gap between PCOS and non-PCOS pregnancies. The point is to make the case for an antenatal package that is genuinely matched to the underlying condition rather than treated as if PCOS were irrelevant once a positive pregnancy test arrives.

The single most important antenatal addition that distinguishes PCOS pregnancy care from general pregnancy care is the early oral glucose tolerance test performed between six and thirteen weeks of pregnancy, in addition to the standard universal OGTT performed between twenty-four and twenty-eight weeks. The reason is that the PCOS metabolic profile of insulin resistance and impaired glucose handling means that a meaningful minority of women with PCOS are already glucose intolerant or have undiagnosed type two diabetes before conception, and the rising insulin demand of early pregnancy unmasks this picture earlier than the standard screening window would catch it. Picking up early gestational diabetes at six to thirteen weeks rather than waiting for the routine screen at twenty-four to twenty-eight weeks gives a four to five month head start on lifestyle changes, on glucose monitoring and where needed on metformin or insulin, and is associated with significantly better outcomes for both mother and baby.

The early OGTT follows the same protocol as the standard one — a seventy-five gram oral glucose load after an overnight fast, with blood samples drawn at zero, one and two hours, and diagnostic cutoffs as per the International Association of the Diabetes and Pregnancy Study Groups criteria that most Indian centres now use of ninety-two milligrams per decilitre fasting, one hundred and eighty at one hour and one hundred and fifty-three at two hours, with one or more values at or above these thresholds confirming gestational diabetes. The test costs roughly four hundred to one thousand rupees at most Indian private laboratories and is provided free at most government antenatal facilities under the Pradhan Mantri Surakshit Matritva Abhiyan programme.

Whatever the result of the early test, the standard OGTT is repeated at twenty-four to twenty-eight weeks because gestational diabetes can develop later in pregnancy even when the early test was normal. For women whose early OGTT confirms gestational diabetes, management starts with diet and exercise advice, moves to capillary blood glucose monitoring four times a day, and adds metformin or insulin if glucose values remain above target. The detailed gestational diabetes pathway including the typical Indian diet adjustment and the cost of glucose meters and strips is laid out in Gestational Diabetes in India: OGTT Screening, Indian Diet Plan and Safe Management.

The recommended total weight gain for a PCOS pregnancy sits at the lower end of the general Institute of Medicine antenatal guidance rather than at the top end, because excess weight gain in pregnancy compounds the existing PCOS-related risk of gestational diabetes, preeclampsia and a large-for-gestational-age baby. The practical numbers are eleven to sixteen kilograms of total pregnancy weight gain for a woman whose pre-pregnancy body mass index sat in the normal range between eighteen and a half and twenty-five, seven to eleven kilograms for a woman whose pre-pregnancy body mass index sat in the overweight range between twenty-five and thirty, and five to nine kilograms for a woman whose pre-pregnancy body mass index sat at thirty or above. Weight gain in the first trimester is typically modest at around one to two kilograms in total, and the bulk of the gain occurs across the second and third trimesters at roughly three hundred to four hundred grams a week.

The point of the lower target is not weight restriction or any return to a calorie-counting mindset. A pregnant woman with PCOS still needs the additional three hundred to four hundred kilocalories a day in the second and third trimesters that any pregnancy requires, still needs the protein and the iron and the calcium and the micronutrients that any pregnancy requires, and should never undereat in the name of staying within a weight gain band. What the lower target does call for is a quality-over-quantity orientation — choosing low glycaemic index millet-based grains over refined wheat and white rice, choosing protein-rich foods that release glucose slowly, choosing fruit and curd snacks over sweet biscuits, and avoiding the daily sweetened chai, sugarcane juice and packaged sherbets that drive postprandial glucose spikes without adding nutritional value.

Weight is checked at every antenatal visit and a sharp upward jump from one visit to the next is a flag for the obstetrician to review the diet pattern, to repeat a capillary glucose check and to look for fluid retention as a possible early sign of preeclampsia. A flat or downward weight curve in the second or third trimester is equally a flag and prompts a careful look at calorie intake, at thyroid status and at any sustained nausea or vomiting that is interfering with eating.

Low-dose aspirin at seventy-five to one hundred and fifty milligrams once a day started from twelve weeks of pregnancy is one of the most studied antenatal medicines in the modern obstetric literature and is recommended by every major international guideline for women at increased risk of preeclampsia. Many women with PCOS fit the risk profile for which aspirin is recommended because of one or more layered factors including a high body mass index, an existing chronic hypertension, an earlier pregnancy complicated by preeclampsia, a multiple pregnancy or a personal or family history of cardiovascular disease, and the obstetrician will make the individual call at the booking visit based on the full risk picture. When aspirin is started it is taken with food at bedtime, is continued through to roughly thirty-six weeks of pregnancy and is then stopped a few days before a planned delivery, and is well tolerated by most women with no impact on the baby. The full preeclampsia prophylaxis and detection picture is laid out in preeclampsia-pregnancy-bp-india.

Metformin at five hundred to one thousand milligrams twice a day is often continued through a PCOS pregnancy if it was already in use for insulin resistance or for the management of overt diabetes, because the modern obstetric literature establishes the safety of metformin in pregnancy and shows a modest reduction in the rates of gestational diabetes, excess weight gain and large-for-gestational-age babies when metformin is continued. The decision whether to continue metformin from before conception, whether to start it freshly during pregnancy on the basis of an early OGTT, or whether to use insulin instead for confirmed gestational diabetes is made by the obstetrician at the individual level rather than as a blanket rule, and the choice depends on the specific glucose pattern, the response to diet and exercise and the woman's tolerance of each medicine.

Both medicines are started and titrated only on the obstetrician's instruction and never on self-medication, both are paired with the standard prenatal vitamins of folic acid, iron, calcium and vitamin D rather than replacing them, and both are reviewed at each antenatal visit so that the dose can be adjusted as the pregnancy progresses.

• Build the everyday plate around low glycaemic index Indian millet grains including ragi, jowar and bajra in preference to refined wheat chapatis made from heavily milled atta and to white rice, because millet-based grains release glucose more slowly into the bloodstream and help moderate the postprandial sugar spikes that drive both gestational diabetes risk and excess fetal growth.
• Pair every meal with a generous serving of protein from dal, curd, paneer, eggs, fish or chicken so that the carbohydrate from the grain is digested more slowly and the satiety from the meal lasts longer, which reduces the inter-meal snacking and the urge for sweet pick-me-ups that tend to drive weight gain in pregnancy.
• Cut out the daily sweetened chai with two teaspoons of sugar, the sugarcane juice, the packaged sherbets and the fruit-flavoured cold drinks that contribute large amounts of glucose with very little nutritional value, and replace them with unsweetened buttermilk, lemon water without sugar, coconut water and plain water as the everyday drinks.
• Walk thirty minutes every day at a moderate pace that lets you talk but not sing, with the walk split into two fifteen-minute segments after the two main meals if a single thirty-minute block is difficult, because post-meal walking is one of the most powerful and most accessible glucose-control interventions available and is safe through pregnancy.
• Add gentle prenatal yoga from the second trimester onwards under an instructor who is trained in pregnancy modifications, focusing on breathing, gentle stretching and pelvic floor work and avoiding lying flat on the back, deep twists, inverted poses and any movement that compresses the abdomen.
• Protect seven to nine hours of night-time sleep because poor sleep worsens insulin resistance and pushes blood pressure up, and use a left lateral sleep position from the late second trimester onwards because it improves blood flow to the placenta and to the baby.
• Build a daily stress reduction practice into the routine because chronic stress raises cortisol and worsens insulin resistance, and even ten minutes of structured breathing, prayer, journaling or a quiet walk in the evening makes a measurable difference over the months of pregnancy.

The single most persistent and most damaging myth that women with polycystic ovary syndrome carry out of the obstetric ward is the belief that pregnancy somehow cures or resets the condition. The clinical reality is the opposite — PCOS is a lifelong metabolic condition with its origins in insulin resistance and androgen excess, and a successful pregnancy is a major life event but is not a cure. The hormonal storm of pregnancy and the early postpartum period can temporarily mask the typical PCOS symptoms because the menstrual cycle is suppressed first by the pregnancy and then by lactational amenorrhoea while breastfeeding is established, but once cycles resume the irregular ovulation, the metabolic patterns and the long-term cardiovascular and diabetes risks all return.

The postpartum period is therefore best thought of as the start of long-term metabolic care rather than the end of an episode. The first concrete handover is a repeat oral glucose tolerance test at six to twelve weeks postpartum for any woman who had gestational diabetes in the pregnancy, because between five and ten percent of these women already have type two diabetes by this point and need to start ongoing diabetes care rather than be discharged with a clean slate. The second handover is a structured conversation with the obstetrician or family doctor about contraception, because PCOS does not protect against unplanned pregnancy even when cycles are irregular and the inter-pregnancy interval is itself a determinant of the next pregnancy's outcome.

The third handover is around mood. Postpartum depression runs at a higher rate in women with PCOS than in the general postpartum population, with the link thought to be a combination of the underlying insulin and androgen patterns, the hormonal swings of the postpartum period and the sleep deprivation of caring for a newborn. The threshold for asking for help, for arranging a postpartum mental health screen and for accepting therapy or medication should be low rather than high, and the family should know that this is an expected vulnerability rather than a personal failing.

• A woman who had gestational diabetes in a PCOS pregnancy carries a lifetime risk of roughly fifty to sixty percent of progressing to overt type two diabetes, with the median time to progression being five to ten years and the risk being highest in the first decade after the pregnancy, which is the window in which screening and lifestyle intervention have the biggest payoff.
• A repeat oral glucose tolerance test or a fasting glucose plus HbA1c is recommended at six to twelve weeks postpartum to catch the small minority who already have type two diabetes at this point and to set a baseline for any woman who had gestational diabetes.
• An annual fasting glucose and HbA1c is then the recommended ongoing screen for any woman who had gestational diabetes, with the screen escalating to a full oral glucose tolerance test if the results drift up over time, and breastfeeding contributing meaningfully to insulin sensitivity through the first year postpartum and so being one of the protective factors to lean into.
• A woman with PCOS who did not develop gestational diabetes still carries a raised lifetime risk of type two diabetes through the underlying insulin resistance pathway, and a fasting glucose with HbA1c every one to three years is the recommended schedule with the interval shortened if there is significant weight gain, a new family history of diabetes or a recurrence of the typical PCOS symptoms.
• Blood pressure and a fasting lipid profile are checked at the same visits because cardiovascular disease risk is also raised in PCOS and rises further with each additional metabolic component, and the same annual visit is the right moment to review weight, waist circumference and any new menstrual changes.
• Most of this screening can be done at the family doctor, at a government primary health centre under the Pradhan Mantri Jan Arogya Yojana coverage or at a local diagnostic chain at modest cost, and does not require ongoing follow-up with the gynaecologist who delivered the baby.

The Indian context for PCOS pregnancy care is shaped by a combination of late diagnosis, family planning pressure and uneven access to reproductive medicine specialists outside the larger cities. PCOS is often diagnosed late in India because the typical early signs of menstrual irregularity and acne are normalised within families and within school health systems, and many women only come to formal diagnosis when they have been trying to conceive for some months without success or when a specific pregnancy complication brings the underlying condition to light. The implication is that pre-conception preparation is often telescoped into the first one or two visits after a positive pregnancy test rather than spread comfortably over the recommended three to six months before conception.

Family planning anxiety and societal pressure also shape the picture. A woman in her late twenties or early thirties who has been trying to conceive for a year is under significant social pressure from extended family, from neighbours and sometimes from her workplace, and the diagnosis of PCOS in this context can compound the stress rather than relieve it. The right framing in the consulting room is to lay out the high success rate of even simple lifestyle and oral ovulation induction interventions, to give a realistic timeline for response and to normalise the gap between diagnosis and pregnancy rather than treat it as a failure.

Access to a fertility specialist or a reproductive endocrinology specialist is concentrated in the larger cities, with the major centres including the All India Institute of Medical Sciences in Delhi and its newer sister institutes, King Edward Memorial Hospital in Mumbai, Christian Medical College in Vellore, Manipal Hospitals across multiple cities, Apollo Hospitals and Cradle centres, Fortis La Femme and the Cloudnine chain. The Pradhan Mantri Jan Arogya Yojana scheme covers diabetes screening, blood pressure monitoring, antenatal care and inpatient delivery for eligible families at empanelled hospitals up to the annual cap of five lakh rupees, and the state-level schemes including the Tamil Nadu Chief Minister's Comprehensive Health Insurance Scheme, the Karnataka Ayushman Bharat Arogya Karnataka scheme and the Rajasthan Mukhyamantri Chiranjeevi Swasthya Bima Yojana add additional coverage for state residents.

• A severe new headache, especially one that does not settle with rest and paracetamol and that is accompanied by visual changes such as blurred vision, double vision or flashing lights, is a red flag for preeclampsia and needs same-day assessment at the labour ward rather than at the next routine antenatal appointment.
• A sudden weight gain of more than two kilograms in a week, especially when accompanied by swelling of the face, the fingers or the legs that does not settle overnight, is another preeclampsia warning sign and needs same-day blood pressure and urine assessment.
• Any vaginal bleeding at any stage of pregnancy is a reason to be seen the same day, with the workup depending on the trimester but always starting with a clinical assessment, an ultrasound where indicated and the appropriate management for the underlying cause.
• Severe abdominal pain that is steady or worsening rather than the intermittent tightening of practice contractions, especially when accompanied by any bleeding, fever, dizziness or shoulder-tip pain, needs urgent assessment because the differential includes preterm labour, placental abruption and other complications that the higher background risk profile of PCOS pregnancy makes more important to catch early.
• A noticeable reduction in fetal movements in the third trimester, after the established movement pattern has settled at around twenty-eight weeks, is a reason to go in for a non-stress test the same day rather than to wait and see, because reduced movements can be one of the earliest signs of fetal compromise.
• Persistent severe vomiting that prevents you from keeping fluids down for more than twelve hours, any sign of a urinary tract infection such as burning, frequency or back pain, and any high fever above thirty-eight and a half degrees Celsius are all reasons to be seen the same day because each carries a higher complication rate in a PCOS pregnancy than in a general pregnancy.